We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$737M
AUM Growth
-$15.3M
Cap. Flow
-$5.45M
Cap. Flow %
-0.74%
Top 10 Hldgs %
24.74%
Holding
518
New
2
Increased
5
Reduced
1
Closed
14

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$1.11M
2
SPHR icon
Sphere Entertainment
SPHR
+$245K
3
NSLR
Neostellar Capital Corp
NSLR
+$23.5K
4
DHR icon
Danaher
DHR
+$272
5
GE icon
GE Aerospace
GE
+$64

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.65M
2
ZWS icon
Zurn Elkay Water Solutions
ZWS
+$1.1M
3
NAV
Navistar International
NAV
+$623K
4
QTS
QTS REALTY TRUST, INC.
QTS
+$618K
5
MSFT icon
Microsoft
MSFT
+$495K

Sector Composition

Rank Sector Weight
1 Technology 24.79%
2 Financials 14.06%
3 Healthcare 12.76%
4 Industrials 11.98%
5 Communication Services 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHS
501
DELISTED
Chicos FAS, Inc.
CHS
$45K 0.01%
10,000
– –
BBGI icon
502
Beasley Broadcasting Group
BBGI
$43.7M
$40K 0.01%
750
– –
LCI
503
DELISTED
Lannett Company, Inc.
LCI
$30K ﹤0.01%
2,500
– –
TLGT
504
DELISTED
Teligent, Inc
TLGT
$10K ﹤0.01%
24,000
– –
EHTH icon
505
eHealth
EHTH
$40.9M
– –
-4,000
Closed -$234K
KBH icon
506
KB Home
KBH
$3.6B
– –
-5,000
Closed -$204K
LAND
507
Gladstone Land Corp
LAND
$349M
– –
-8,600
Closed -$207K
UNH icon
508
UnitedHealth
UNH
$376B
– –
-500
Closed -$200K
VMEO
509
DELISTED
Vimeo
VMEO
– –
-6,291
Closed -$308K
VRTX icon
510
Vertex Pharmaceuticals
VRTX
$123B
– –
-1,000
Closed -$202K
ZWS icon
511
Zurn Elkay Water Solutions
ZWS
$8.79B
– –
-45,672
Closed -$1.1M
WWE
512
DELISTED
World Wrestling Entertainment
WWE
– –
-3,500
Closed -$203K
DISCK
513
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
– –
-7,500
Closed -$217K
QTS
514
DELISTED
QTS REALTY TRUST, INC.
QTS
– –
-8,000
Closed -$618K
KIN
515
DELISTED
Kindred Biosciences, Inc.
KIN
– –
-32,000
Closed -$293K
ALXN
516
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-9,000
Closed -$1.65M
MSGN
517
DELISTED
MSG Networks Inc.
MSGN
– –
-19,000
Closed -$277K
NAV
518
DELISTED
Navistar International
NAV
– –
-14,000
Closed -$623K
17 18 19 20
21

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q3 2021 Portfolio in Review

As of Q3 2021, NJ State Employees Deferred Compensation Plan held 518 positions worth $737M, down 2% from $752M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 3.1%. NJ State Employees Deferred Compensation Plan opened 2 new positions and exited 14, leaving the 518-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • NJ State Employees Deferred Compensation Plan's largest Q3 2021 buy was AstraZeneca: 9,560 shares worth $1.15M.
  • NJ State Employees Deferred Compensation Plan added most to Neostellar Capital Corp in Q3 2021, an estimated $23.5K increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q3 2021 reduction was Microsoft, cutting an estimated $495K.
  • NJ State Employees Deferred Compensation Plan fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.65M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 25% of its $737M portfolio in Q3 2021.
  • NJ State Employees Deferred Compensation Plan opened 2 new positions and closed 14 in Q3 2021.
  • NJ State Employees Deferred Compensation Plan's portfolio value fell 2% quarter-over-quarter to $737M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2021, filed 26 Oct 2021.